Skip to content
← Back to search

International registration designating the UK WO0000000873066

ABREAST A Breast Cancer Registry of Adjuvant Strategies

DeadFigurative
TM

Official representation

Trade mark image

Stored locally from an official UKIPO, EUIPO or WIPO source and matched by the exact registration number.

Official representation of trade mark WO0000000873066 — ABREAST A Breast Cancer Registry of Adjuvant Strategies
Official WIPO representation · 207 × 70 px

Registration details

Trade mark number
WO0000000873066
Status in snapshot
Dead
Filed / designated
2 Feb 2006
Published
7 Apr 2006
Registered / protected
8 Jul 2006
International registration valid until
23 Sep 2025 · WIPO update 6 Apr 2026
Expired
23 Sep 2015
Category
Standard
Mark type
Figurative

Owner

Nice classes

Official source data

Additional trade mark details

Current Madrid designations
CN
International registration valid until
2025-09-23
International registration date
2005-09-23
WIPO office of origin
FR
Vienna image classification
0105, 2705, 010502, 270501

Nice classification

Goods and services

Wording supplied in the official WIPO ROMARIN update WIPO-20260406.

Class 5

Pharmaceutical preparations for treating cancer.

Class 35

Creation of a medical database on the treatment of cancer.

Class 42

Scientific research for medical purposes, clinical studies in the field of cancer; establishing development and clinical experimentation protocols in connection with pharmaceutical preparations and their development; establishing a study protocol for collecting data on the way practitioners treat cancer, without asking them to apply a particular procedure or technique or to use one or more given pharmaceutical preparations; professional consulting on the development of pharmaceutical preparations against cancer.

Class 44

Professional consulting in connection with pharmaceutical preparations against cancer, in the context of administering medical care; medical information in connection with manufacturing, operating and using pharmaceutical preparations against cancer.